Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
Laia RevertéElena YereguiMontserrat OlonaAlicia Gutiérrez-ValenciaMaria José BuzónAnna MartíFrederic Gómez-BertomeuTeresa AuguetLuis F López-CortésJoaquin BurgosClara Benavent-BofillCarme BoquéGraciano García-PardoEzequiel Ruiz-MateosMaria Teresa MestreFrancesc VidalConsuelo ViladésJoaquim PeraireAnna Rullnull nullPublished in: Clinical and translational medicine (2022)